Form 8-K - Current report:
SEC Accession No. 0001104659-25-059351
Filing Date
2025-06-13
Accepted
2025-06-13 16:07:56
Documents
12
Period of Report
2025-06-11
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2517926d1_8k.htm   iXBRL 8-K 35884
  Complete submission text file 0001104659-25-059351.txt   201723

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA chrs-20250611.xsd EX-101.SCH 3011
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE chrs-20250611_lab.xml EX-101.LAB 34239
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE chrs-20250611_pre.xml EX-101.PRE 22356
14 EXTRACTED XBRL INSTANCE DOCUMENT tm2517926d1_8k_htm.xml XML 3695
Mailing Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065
Business Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065 (650) 649-3530
Coherus Oncology, Inc. (Filer) CIK: 0001512762 (see all company filings)

EIN.: 273615821 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36721 | Film No.: 251046571
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)